Machine Learning Based Plasma Proteomic Analysis Identifies Disease Differentiating Biomarkers in Atopic Dermatitis
BACKGROUND: Inflammatory diseases consist of a diverse group of conditions characterized by immune responses leading to inflammation causing damage and abnormality in function. Atopic dermatitis (AD) and ulcerative colitis (UC) both exhibit aberrant Th2 cell activity, leading to epithelial barrier dysfunction in the skin and gut, respectively. Although both diseases share similar features, differences in their tissue-specific pathology, clinical manifestations, and immune profiles may provide valuable insights into the distinct mechanisms underlying each disease. METHODS: We used the high-throughput Olink 384 proximity extension assay platform to profile plasma proteins from 58 patients with AD or UC and 29 healthy subjects. Differentially expressed proteins (DEPs) were identified and machine-learning (ML) model using least absolute shrinkage and selection operator (LASSO) regression was conducted to select disease-differentiating biomarkers. Pearson correlation analysis was performed to identify protein modules associated with severity of AD. RESULTS: DEP analysis yielded 85 (35 unique) and 99 (49 unique) upregulated proteins in AD and UC, respectively, compared to healthy subjects. We integrated an ML model and selected 24 proteins to distinguish between the diseases, which accurately predicted disease-differentiating biomarkers based on distinctive proteomic signatures and disease severity. Using nested cross-validation approach, we achieved robust classification performance with a mean area under the receiver operating characteristic curve of 0.99 ± 0.01. Correlation analysis with disease severity identified upregulated ML-selected proteins such as CCL13, CCL26, CD70, CDON, LY6D and MMP1 in AD, and ITM2A and REG4 in UC. Among these identified proteins, we suggest CDON, CD70, and LY6D, which had highly correlated expression levels, as AD-specific biomarkers. CONCLUSION: Our study provides insight into the application of ML algorithms for disease diagnosis, and our model may be expanded to other disease contexts. Our results identify inflammatory protein biomarkers and suggest their relevance in predicting disease severity, monitoring clinical progression and future therapeutic strategies.
Authors
- Christine Suh-Yun Joh (ORCID: https://orcid.org/0009-0005-6773-4265)
- Yoon Ji Bang (ORCID: https://orcid.org/0000-0002-1539-6277)
- Soyoung Jeong (ORCID: https://orcid.org/0000-0003-0911-0567)
- Minsik Oh (ORCID: https://orcid.org/0000-0003-4170-1543)
- Ji Hwan Moon (ORCID: https://orcid.org/0000-0002-0172-4428)
- Jong Wook Jung (ORCID: https://orcid.org/0009-0006-9149-2064)
- Jaeyun Park (ORCID: https://orcid.org/0009-0007-0799-3286)
- Jasper Roldan Go (ORCID: https://orcid.org/0009-0009-4350-3437)
- Hyun Je Kim (ORCID: https://orcid.org/0000-0003-4467-0949)
Institutions
- Seoul National University (KR)
- Samsung Medical Center (KR)
- Myongji University (KR)
Publication Details
- Journal
- Journal of Korean Medical Science
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3346/jkms.2026.41.e276
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation of Korea
- Institute for Information and Communications Technology Promotion